GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently emerging as a significant focus in medical studies, largely due to its impressive impact on treating diseases such as second type diabetes and obesity. Ongoing trials have demonstrated that more than glucose control, GLP-1 agonists offer potential for cardiovascular well-be… Read More